HRP921337B1 - Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent - Google Patents

Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent

Info

Publication number
HRP921337B1
HRP921337B1 HRP-945A HRP921337A HRP921337B1 HR P921337 B1 HRP921337 B1 HR P921337B1 HR P921337 A HRP921337 A HR P921337A HR P921337 B1 HRP921337 B1 HR P921337B1
Authority
HR
Croatia
Prior art keywords
carboxy
ethylamino
complex salts
propylamino
hematoporphyrin
Prior art date
Application number
HRP-945A
Other languages
English (en)
Inventor
Alfreda Graczyk
Jerzy Konarski
Original Assignee
Wojskowa Akad Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wojskowa Akad Tech filed Critical Wojskowa Akad Tech
Publication of HRP921337A2 publication Critical patent/HRP921337A2/hr
Publication of HRP921337B1 publication Critical patent/HRP921337B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HRP-945A 1991-10-29 1992-11-24 Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent HRP921337B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL91292220A PL165249B1 (pl) 1991-10-29 1991-10-29 Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
YU94592A YU48961B (sh) 1991-10-29 1992-10-29 Kompleksne soli hematoporfirina i njegovih derivata i njihova sinteza

Publications (2)

Publication Number Publication Date
HRP921337A2 HRP921337A2 (en) 1994-10-31
HRP921337B1 true HRP921337B1 (en) 2000-02-29

Family

ID=20055985

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-945A HRP921337B1 (en) 1991-10-29 1992-11-24 Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent

Country Status (18)

Country Link
US (1) US5451599A (cs)
EP (1) EP0539960B1 (cs)
JP (1) JP3020759B2 (cs)
CN (1) CN1040328C (cs)
BG (1) BG61648B1 (cs)
CA (1) CA2081605C (cs)
CZ (1) CZ281694B6 (cs)
DE (1) DE69217819T2 (cs)
DK (1) DK0539960T3 (cs)
FI (1) FI100243B (cs)
HR (1) HRP921337B1 (cs)
LV (1) LV11952B (cs)
NO (1) NO300499B1 (cs)
PL (1) PL165249B1 (cs)
RU (1) RU2122003C1 (cs)
SI (1) SI9200286B (cs)
UA (1) UA40568C2 (cs)
YU (1) YU48961B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
RU2164136C2 (ru) * 1998-09-09 2001-03-20 Государственный научный центр РФ "НИОПИК" Фотосенсибилизатор для фотодинамической терапии
KR100980153B1 (ko) 2000-11-29 2010-09-03 피씨아이 바이오테크 에이에스 사이토졸 내로의 분자 전달을 위한 광화학적 내부이행
PL213376B1 (pl) 2000-11-29 2013-02-28 Pci Biotech As Fotochemiczny sposób in vitro lub ex vivo wprowadzania czasteczki do komórki za posrednictwem nosnika adenowirusowego, kompozycja farmaceutyczna, zastosowanie i produkt
RU2236411C2 (ru) * 2002-06-06 2004-09-20 Московская государственная академия тонкой химической технологии им. М.В. Ломоносова Металлокомплексы карборанилпорфиринов, обладающие противоопухолевой активностью
RU2278119C1 (ru) * 2004-12-06 2006-06-20 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Тетраазахлорины как фотосенсибилизаторы для фотодинамической терапии
RU2282647C1 (ru) * 2005-05-31 2006-08-27 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизаторы для антимикробной фотодинамической терапии
RU2282646C1 (ru) * 2005-05-31 2006-08-27 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизаторы для фотодинамической терапии
CN104130266A (zh) * 2013-05-02 2014-11-05 中国医学科学院生物医学工程研究所 一种新型原卟啉衍生物及制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (fr) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Dichlorhydrate d'hématoporphyrinate de procaine.
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
JPS60152487A (ja) * 1984-01-18 1985-08-10 Sato Yakugaku Kenkyusho:Kk デユウテロポルフイリン誘導体及びその塩
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
JPH0764728B2 (ja) * 1985-04-30 1995-07-12 日本石油化学株式会社 新規なテトラピロ−ル医薬用組成物
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
DE3687399T2 (de) * 1985-10-23 1993-04-29 Nihon Mediphysics Co Ltd Porphyrinderivate, ihre herstellung und verwendung.
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
JPH0786109B2 (ja) * 1987-12-21 1995-09-20 浜理薬品工業株式会社 フェオフォルバイド誘導体
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4965054A (en) * 1989-08-01 1990-10-23 Henkel Corporation Process of extraction of gallium from aqueous solutions thereof
CN102565846B (zh) * 2011-12-30 2014-05-14 清华大学 蜂窝型热中子探测器

Also Published As

Publication number Publication date
YU48961B (sh) 2003-01-31
DE69217819D1 (de) 1997-04-10
NO924151L (no) 1993-04-30
JP3020759B2 (ja) 2000-03-15
HRP921337A2 (en) 1994-10-31
FI924856A0 (fi) 1992-10-26
BG97030A (bg) 1994-03-24
NO300499B1 (no) 1997-06-09
CA2081605C (en) 2002-02-26
FI924856A7 (fi) 1993-04-30
NO924151D0 (no) 1992-10-28
CA2081605A1 (en) 1993-04-30
UA40568C2 (uk) 2001-08-15
SI9200286B (en) 2001-06-30
BG61648B1 (bg) 1998-02-27
DE69217819T2 (de) 1997-09-04
JPH05262775A (ja) 1993-10-12
EP0539960B1 (en) 1997-03-05
US5451599A (en) 1995-09-19
CZ325292A3 (en) 1993-09-15
DK0539960T3 (da) 1997-09-15
CN1040328C (zh) 1998-10-21
LV11952A (lv) 1998-01-20
EP0539960A2 (en) 1993-05-05
CN1071914A (zh) 1993-05-12
PL292220A1 (en) 1993-09-20
RU2122003C1 (ru) 1998-11-20
YU94592A (sh) 1995-12-04
CZ281694B6 (cs) 1996-12-11
LV11952B (en) 1998-06-20
FI100243B (fi) 1997-10-31
PL165249B1 (pl) 1994-11-30
SI9200286A (en) 1993-06-30
EP0539960A3 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
HRP921337B1 (en) Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent
IL70286A0 (en) Analogs of mevalolactone and derivatives thereof,their production and pharmaceutical compositions containing them
DE122004000034I2 (de) Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür
DK0835888T3 (da) En ikke-tværbundet anionbytterharpiks og farmaceutisk sammensætning indeholdende denne
HUT37380A (en) Process for producing mevalomolaktone analoguse and derivatives and pharmaceutical compositions containing them
ES8306371A1 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
IL86487A (en) Un-natural ceramide related compounds and preparation thereof
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
PT90635A (pt) Processo para a preparacao de derivados do acido n-(5,6,7,8-tetra-hidropirido-{2,3-d}pirimidin-6-il-alcanoil)glutamico
IE831479L (en) 2-alkylidene-1, 3-dithiaheterocyclic compounds
ITRM910327A1 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
RU92004314A (ru) Комплексные соли гематопорфирина и его производных, способ их производства и фармацевтическое средство
IL63648A0 (en) Azolylalkyl derivatives,their preparation and their use as fungicides
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
CZ228195A3 (en) Derivatives of hydroxymethylfurazancarboxylic acid, process of their preparation, their use for treating cardiovascular diseases and a pharmaceutical composition containing thereof
EP0330413A3 (en) Method for inhibition of scale formation, compositions thereof and method for preparation of such compositions
HU9601701D0 (en) Aromatic hydroxamic acid compounds, process for producing them and their use
BG60209B2 (bg) Метод за получаване на производни на дихидро- пиримидотиазин
DE68902887D1 (de) Propargylguanidin-derivate und verfahren zu deren herstellung.
JPS56156293A (en) Ethylene glycol derivative
ATE47839T1 (de) N-(2,6-disubstituierte aryl)-n'pyridinylharnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
LTIP1787A (en) Novel acrylic amide derivatives, aprocess for their preparation, pharmaceutical compositions containing the same and their use in medicine

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: NAPTA" S.A., "NARODOWA AGENCJA FOTODYNAMICZNEJ DIA

ODRP Renewal fee for the maintenance of a patent

Payment date: 20101020

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20111030